Identification of oligodendrocytes in experimental disease models
- 21 April 2005
- Vol. 50 (4) , 321-328
- https://doi.org/10.1002/glia.20206
Abstract
The ability to identify oligodendrocytes in culture, in fixed tissue, and in vivo using unique markers is a requisite step to understanding their responses in any damage, recovery, or developmental process. Their nuclei are readily seen in histological preparations of healthy white and gray matter, and their cell bodies can be reliably identified with a variety of immunocytochemical markers. However, there is little consensus regarding optimal methods to assess oligodendrocyte survival or morphology under experimental injury conditions. We review common approaches for histological and immunocytochemical identification of these cells. Transgenic and viral methods for cell type‐selective transfer of genes encoding fluorescent proteins offer promising new approaches for manipulating and visualizing oligodendrocytes in models of health and disease.Keywords
This publication has 46 references indexed in Scilit:
- In Vivo Gene Transfer to Cerebral White Matter Lesions with a Recombinant Adenovirus VectorBiochemical and Biophysical Research Communications, 2001
- Caspases determine the vulnerability of oligodendrocytes in the ischemic brainJournal of Clinical Investigation, 2000
- Quantitative Assessment of Ischemic Pathology in Axons, Oligodendrocytes, and Neurons: Attenuation of Damage after Transient IschemiaJournal of Cerebral Blood Flow & Metabolism, 2000
- Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic miceJournal of Neuroscience Research, 1998
- Cerebral White Matter Is Highly Vulnerable to IschemiaStroke, 1996
- Expression of the APC tumor suppressor protein in oligodendrogliaGlia, 1996
- The Significance of Cerebral White Matter Abnormalities 100 Years After Binswanger’s ReportStroke, 1995
- A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice.The Journal of cell biology, 1993
- A novel myelin-associated glycoprotein defined by a mouse monoclonal antibodyJournal of Neuroimmunology, 1984
- Immunochemical Identification of 2′, 3′‐Cyclic Nucleotide 3′‐Phosphodiesterase in Central and Peripheral Nervous System Myelin, the Wolfgram Protein Fraction, and Bovine OligodendrocytesJournal of Neurochemistry, 1983